← Back to Search

Behavioral Intervention

PD - individuals with Parkinson Disease, either male or female for Parkinson's Disease (SegwayPD Trial)

N/A

Recruiting

Led By Yasin Dhaher, Ph.D.

Research Sponsored by University of Texas Southwestern Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

the ability to stand and walk unsupported for 5 min both on and off medication

a clinical diagnosis of idiopathic PD with moderate disease stage presenting balance alterations (Hoehn and Yahr stage III)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1 (2 assessments), week 3 (1assessment)

Awards & highlights

SegwayPD Trial Summary

This trial investigates the safety and effectiveness of a postural training program for people with Parkinson's Disease, using a Segway platform to provide proprioceptive and visual information.

Who is the study for?

This trial is for individuals aged 50-85 with idiopathic Parkinson's Disease at a moderate stage (Hoehn and Yahr stage III), who can stand and walk unaided for 5 minutes, whether on or off medication. They must have been stable on their current medication for at least one month.Check my eligibility

What is being tested?

The study tests the safety and effectiveness of sensory-augmented postural training using a Segway to improve balance in Parkinson's patients by providing continuous proprioceptive (body position sense) and visuospatial (space around us) feedback during exercises.See study design

What are the potential side effects?

While not explicitly listed, potential side effects may include discomfort or fatigue from physical activity, dizziness or falls due to balance challenges while using the Segway, and possible overstimulation from augmented sensory input.

SegwayPD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I can stand and walk by myself for 5 minutes, with or without medication.

Select...

I have Parkinson's disease at stage III, affecting my balance.

Select...

I am between 50 and 85 years old.

SegwayPD Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1 (2 assessments), week 3 (1assessment)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1 (2 assessments), week 3 (1assessment)

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1 (2 assessments), week 3 (1assessment) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change from baseline postural sway at week 3

Secondary outcome measures

Change from baseline EEG spectral ratio at week 3

Change from baseline gait spatiotemporal parameters at week 3

Feasibility of Segway training

SegwayPD Trial Design

1Treatment groups

Experimental Treatment

Group I: PD - individuals with Parkinson Disease, either male or femaleExperimental Treatment1 Intervention

Individuals, aged 50-85, with a clinical diagnosis of idiopathic Parkinson Disease, either male or female, with moderate disease stage presenting balance alterations (Hoehn or Yahr stage III)

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Texas Southwestern Medical CenterLead Sponsor

1,048 Previous Clinical Trials

1,053,720 Total Patients Enrolled

Yasin Dhaher, Ph.D.Principal InvestigatorUniversity of Texas Southwestern Medical Center

1 Previous Clinical Trials

70 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it possible for senior citizens to be included in this research endeavor?

"The minimal age for enrolment in this clinical trial is 50 years old, while the upper limit of inclusion stands at 85."

Answered by AI

Are there any open slots remaining for participants in this research endeavor?

"Indeed, the up-to-date clinicaltrials.gov records demonstrate that this research is actively looking for volunteers. The trial was first featured on November 8th 2023 and has been updated as recently as December 12th of the same year. 15 individuals are needed to be recruited from one medical centre."

Answered by AI

Who has been identified as the ideal demographic for this clinical trial?

"This clinical trial is accepting 15 participants aged between 50 and 85, who have been diagnosed with Parkinson's disease. Applicants need to meet further criteria including a moderate stage of the illness alongside balance issues (Hoehn and Yahr stage III), standing/walking ability without aid for five minutes on or off medication, and stability in their treatment regimen for at least one month."

Answered by AI

How many individuals are being recruited to participate in this trial?

"Affirmative. As of this moment, the information present on clinicaltrials.gov shows that recruiting for this experiment is ongoing, with data posted initially on November 8th 2023 and last updated December 12th 2023. The trial necessitates 15 participants from 1 medical centre to be enrolled in order for it to continue its progress."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease

Yasin Dhaher 2023. "SegwayPD: The Effect of Sensory-augmented Postural Training Using Segway on Motor and Cognitive Function in Individuals With Parkinson's Disease". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05982730.